Co-expression of CD173 (H2) and CD174 (Lewis Y) with CD44 suggests that fucosylated histo-blood group antigens are markers of breast cancer-initiating cells.

Lin WM, Karsten U, Goletz S, Cheng RC, Cao Y. Virchows Arch. 2010 Apr;456(4):403-9. doi: 10.1007/s00428-010-0897-5.

Read more
Reactivity of a humanized antibody (hPankoMab) towards a tumor-related MUC1 epitope (TA-MUC1) with various human carcinomas.

Fan XN, Karsten U, Goletz S, Cao Y. Pathol Res Pract. 2010 Aug 15;206(8):585-9. doi: 10.1016/j.prp.2010.03.006.

Read more
A novel series of anti-human glycophorin A (CD235a) antibodies defining five extra- and intracellular epitopes.

Karsten U, Butschak G, Stahn R, Goletz S. Int Immunopharmacol. 2010 Nov;10(11):1354-60. doi: 10.1016/j.intimp.2010.08.001.

Read more
Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells.

Lin WM, Karsten U, Goletz S, Cheng RC, Cao Y. Int J Exp Pathol. 2011 Apr;92(2):97-105. doi: 10.1111/j.1365-2613.2010.00747.x.

Read more
A Matter of Cell Line Development.

Baumeister H, Goletz S. In: European BioPharmaceutical Review 2010: Apr.